These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34057235)

  • 1. Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
    Oechtering J; Schaedelin S; Benkert P; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Fischer-Barnicol B; Orleth A; Chan A; Pot C; Barakovic M; Rahmanzadeh R; Galbusera R; Heijnen I; Lalive PH; Wuerfel J; Subramaniam S; Aeschbacher S; Conen D; Naegelin Y; Maceski A; Meier S; Berger K; Wiendl H; Lincke T; Lieb J; Yaldizli Ö; Sinnecker T; Derfuss T; Regeniter A; Zecca C; Gobbi C; Kappos L; Granziera C; Leppert D; Kuhle J;
    Ann Neurol; 2021 Sep; 90(3):477-489. PubMed ID: 34057235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
    Oechtering J; Lincke T; Schaedelin S; Décard BF; Maceski A; Orleth A; Meier S; Willemse E; Buchmann A; Khalil M; Derfuss T; Benkert P; Heijnen I; Regeniter A; Müller S; Achtnichts L; Lalive P; Salmen A; Pot C; Gobbi C; Kappos L; Granziera C; Leppert D; Schlaeger R; Lieb JM; Kuhle J;
    Ann Neurol; 2022 Jun; 91(6):814-820. PubMed ID: 35293622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis.
    Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
    Front Immunol; 2022; 13():967953. PubMed ID: 36032114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
    Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
    Calabrese M; Federle L; Bernardi V; Rinaldi F; Favaretto A; Varagnolo MC; Perini P; Plebani M; Gallo P
    Mult Scler; 2012 Feb; 18(2):174-80. PubMed ID: 21868488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
    Maggi P; Kuhle J; Schädelin S; van der Meer F; Weigel M; Galbusera R; Mathias A; Lu PJ; Rahmanzadeh R; Benkert P; La Rosa F; Bach Cuadra M; Sati P; Théaudin M; Pot C; van Pesch V; Leppert D; Stadelmann C; Kappos L; Du Pasquier R; Reich DS; Absinta M; Granziera C
    Neurology; 2021 Aug; 97(6):e543-e553. PubMed ID: 34088875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study.
    Hegen H; Berek K; Bsteh G; Auer M; Altmann P; Di Pauli F; Grams A; Milosavljevic D; Ponleitner M; Poskaite P; Schnabl C; Wurth S; Zinganell A; Berger T; Walde J; Deisenhammer F
    EBioMedicine; 2023 May; 91():104573. PubMed ID: 37086651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
    Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
    J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS.
    Chen S; A B; Koukou G; Wendel EM; Thiels C; Baumann M; Lechner C; Blaschek A; Della Marina A; Classen G; Stüve B; Kauffmann B; Kapanci T; Mayer B; Otto M; Rostásy K
    Eur J Paediatr Neurol; 2024 May; 50():51-56. PubMed ID: 38636242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
    Stauch C; Reiber H; Rauchenzauner M; Strasak A; Pohl D; Hanefeld F; Gärtner J; Rostásy KM
    Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
    Fox RJ; Cree BAC; de Sèze J; Gold R; Hartung HP; Jeffery D; Kappos L; Montalban X; Weinstock-Guttman B; Singh CM; Altincatal A; Belviso N; Avila RL; Ho PR; Su R; Engle R; Sangurdekar D; de Moor C; Fisher E; Kieseier BC; Rudick RA
    Neurology; 2024 May; 102(9):e209357. PubMed ID: 38648580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can CSF biomarkers predict future MS disease activity and severity?
    Magliozzi R; Cross AH
    Mult Scler; 2020 Apr; 26(5):582-590. PubMed ID: 31965889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF parameters associated with early MRI activity in patients with MS.
    Klein A; Selter RC; Hapfelmeier A; Berthele A; Müller-Myhsok B; Pongratz V; Gasperi C; Zimmer C; Mühlau M; Hemmer B
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e573. PubMed ID: 31355309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple Sclerosis.
    Huppke B; Reinert MC; Hummel-Abmeier H; Stark W; Gärtner J; Huppke P
    Neurology; 2023 Nov; 101(19):e1873-e1883. PubMed ID: 37748882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.